Latest News by Industry
• The agency said it will provide an update as it learns more
The Food and Drug Administration said it is investigating another case of a child’s death after allegedly consuming Abbott Laboratories’ (NYSE: ABT) baby formula.
The FDA said it has initiated an investigation, given that the complaint referenced that the infant had consumed an Abbott product.
“However, the investigation of this most recent consumer complaint is in its preliminary stages and the agency will provide an update as it learns more,” said the agency.
According to the complaint, which was filed on June 10, 2022, the infant died in January 2022.
The FDA said that it has reviewed and investigated a total of 129 complaints associated with Abbott Nutrition formula products.
Of these, 119 complaints were reported after Abbott voluntarily recalled product on February 17, it added.
Picture Credits: WSJ
ALSO READ: